Advanced Drainage Systems to buy StormTrap for about $530 million
Bitget2026/10/05 10:45ADS agreed to buy StormTrap Investments from PSP Capital for about $530 million, or about $450 million adjusted for expected tax benefits. Deal expands ADS into large-volume, space-constrained stormwater storage and treatment systems, strengthening its offering in commercial and infrastructure projects. StormTrap posted about $165 million revenue, about $40 million adjusted EBITDA for the 12 months ended July 2026. Net valuation implies about 10x adjusted EBITDA, including expected run-rate cost synergies; funding set from cash and existing credit lines. Closing targeted for the fourth quarter of calendar 2026, subject to customary closing conditions and required regulatory approvals. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADS - Advanced Drainage Systems Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610050645BIZWIRE_USPR_____20261005_BW997833) on October 05, 2026, and is solely responsible for the information contained therein.
- ADS agreed to buy StormTrap Investments from PSP Capital for about $530 million, or about $450 million adjusted for expected tax benefits.
- Deal expands ADS into large-volume, space-constrained stormwater storage and treatment systems, strengthening its offering in commercial and infrastructure projects.
- StormTrap posted about $165 million revenue, about $40 million adjusted EBITDA for the 12 months ended July 2026.
- Net valuation implies about 10x adjusted EBITDA, including expected run-rate cost synergies; funding set from cash and existing credit lines.
- Closing targeted for the fourth quarter of calendar 2026, subject to customary closing conditions and required regulatory approvals.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Indonesian Rupiah: Limited relief, challenging backdrop – OCBC
Buying Wind in the Cryptocurrency Market! Significant Activity in Bitcoin, Ethereum, and Solana! Here are the Details…
Hulamin says Paul Baloyi resigns as independent non-executive director
Hulamin said independent non-executive director Paul Baloyi resigned, effective Oct. 2, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hulamin Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S604350), on October 05, 2026, and is solely responsible for the information contained therein.
US Stock Move | Pneumococcal vaccine achieves late-stage clinical trial target, Vaxcyte (PCVX.US) opens more than 50% higher
On Monday, Vaxcyte (PCVX.US) soared more than 50% at the open and was up approximately 53% at the time of writing, with a market capitalization of 12.8 billions USD.
Crypto prices
More
